Clinical Trials of Niclosamide, Repurposed Drug For COVID-19 Treatment, Initiated by CSIR India & Laxai Life Sciences
CSIR India and Laxai Life Sciences on Sunday initiated clinical trials of repurposed drug Niclosamide for COVID-19 treatment. The Ministry of Science and Technology said, "The trial is multi-centric, phase-II, randomized, open label clinical study to evaluate efficacy, safety and tolerability of the drug."
Clinical Trials of Niclosamide, Repurposed Drug For COVID-19 Treatment, Initiated by CSIR India & Laxai Life Sciences:
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)